These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25257702)

  • 1. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer.
    Wang X; Meng X; Li H; Liu W; Shen S; Gao Z
    Clin Transl Oncol; 2014 Nov; 16(11):954-8. PubMed ID: 24696291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.
    Zhou QH; Zhao YM; Jia LL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4278-4282. PubMed ID: 29077170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
    Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A
    PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M; Yang Z; Ye W; Xu H; Hua X
    PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation.
    Qin CZ; Lou XY; Lv QL; Cheng L; Wu NY; Hu L; Zhou HH
    Pharmazie; 2015 Oct; 70(10):668-73. PubMed ID: 26601424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
    Nodin B; Zendehrokh N; Sundström M; Jirström K
    Diagn Pathol; 2013 Jun; 8():106. PubMed ID: 23800114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.
    Zhang B; Li Y; Li Y; Zhao H; An R
    Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.
    Wang S; Zhao X; Wang J; Wen Y; Zhang L; Wang D; Chen H; Chen Q; Xiang W
    Med Oncol; 2013; 30(3):681. PubMed ID: 23918241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
    Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
    Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA let-7a modifies the effect of self-renewal gene HIWI on patient survival of epithelial ovarian cancer.
    Lu L; Katsaros D; Risch HA; Canuto EM; Biglia N; Yu H
    Mol Carcinog; 2016 Apr; 55(4):357-65. PubMed ID: 25630839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
    Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
    Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
    Cao Q; Lu K; Dai S; Hu Y; Fan W
    Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.